We’ve combined our tools and data to help you accelerate your drug development program
For all of our products we use a suite of human genetic tools to allow you to attract investment and make critical pipeline decisions.
Target Intelligence Reports
This product helps you understand the human genetic evidence supporting a specific drug target for a disease indication.
This is useful for biotech, pharma and their investors who want to know if human genetic evidence supports their drug development program.
Disease Intelligence Reports
This product allows you to understand which targets
in the human genome have the best human genetic evidence for a specific disease.
This is the ideal product for early-stage drug developers who understand that drug development programs based on human genetics are more likely to succeed to market.
